Evidence map›Paper›PMID 32790451›Full record

Trial reportJournal of consulting and clinical psychology2020

Mobile enhancement of motivation in schizophrenia: A pilot randomized controlled trial of a personalized text message intervention for motivation deficits.

Lauren Luther, Melanie W Fischer, Annalee V Johnson-Kwochka, Kyle S Minor, Richard Holden, Chris L Lapish, Bryan McCormick, Michelle P Salyers

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of consulting and clinical psychology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lauren LutherDepartment of Psychiatry, Massachusetts General Hospital.
Melanie W FischerDepartment of Psychology, Indiana University-Purdue University Indianapolis.
Annalee V Johnson-KwochkaDepartment of Psychology, Indiana University-Purdue University Indianapolis.ORCID 0000-0002-7455-4546
Kyle S MinorDepartment of Psychology, Indiana University-Purdue University Indianapolis.
Richard HoldenDepartment of Medicine, Indiana University School of Medicine.
Chris L LapishDepartment of Psychology, Indiana University-Purdue University Indianapolis.ORCID 0000-0002-4388-4438
Bryan McCormickDepartment of Health and Rehabilitation Sciences in the College of Public Health, Temple University.ORCID 0000-0003-1017-8868
Michelle P SalyersDepartment of Psychology, Indiana University-Purdue University Indianapolis.
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineMassachusetts General Hospital · USTemple College · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Stuart T. Hauser Research Training Program in Biological and Social Psychiatry.T32MH016259 · NIMH · JUDGE BAKER CHILDREN'S CENTER · PI Marek Kubicki, Martha E. Shenton · 1985 to 2026
$8.4M
American Psychological FoundationIndiana Clinical and Translational Sciences InstituteIndiana Clinical and Translational Sciences Institute; Clinical Research CenterNCATS NIH HHS UL1 TR001108NIMH NIH HHS T32 MH016259
6 · The paper itself

Abstract

objectiveMotivation deficits remain an unmet treatment need in schizophrenia. Recent research has identified mechanisms underlying motivation deficits (i.e., impaired effort-cost computations, reduced future reward-value representation maintenance) that may be effective treatment targets to improve motivation. This study tested the feasibility and preliminary effectiveness of Mobile Enhancement of Motivation in Schizophrenia (MEMS), an intervention that leverages mobile technology to target these mechanisms with text messages.

methodFifty-six participants with a schizophrenia-spectrum disorder were randomized to MEMS (n = 27) or a control condition (n = 29). All participants set recovery goals to complete over 8 weeks. Participants in the MEMS group additionally received personalized, interactive text messages on their personal cellphones each weekday.

resultsRetention and engagement in MEMS were high: 92.6% completed 8 weeks of MEMS, with an 86.1% text message response rate, and 100% reported being satisfied with the text messages. Compared to participants in the control condition, the participants in the MEMS condition had significantly greater improvements in interviewer-rated motivation and anticipatory pleasure and attained significantly more recovery-oriented goals at 8 weeks. There were no significant group differences in purported mechanisms (performance-based effort-cost computations and future reward-value representations) or in self-reported motivation, quality of life, or functioning.

conclusionResults demonstrate that MEMS is feasible as a brief, low-intensity mobile intervention that could effectively improve some aspects of motivation (i.e., initiation and maintenance of goal-directed behaviors) and recovery goal attainment for those with schizophrenia-spectrum disorders. More work is needed with larger samples and to understand the mechanisms of change in MEMS. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Indexed as

MotivationSchizophreniaSchizophrenic PsychologyText MessagingAdultFemaleHumansMaleMiddle AgedPilot ProjectsPsychotic DisordersQuality of LifeRewardTreatment Outcome

Identifiers

PMID32790451
PMCPMC9836765
OpenAlexW3049071157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.